Cytiva– tag –
-
Small-Scale Bioreactors Market Sees Robust Growth Driven by Innovation; Culture Biosciences and Cytiva Bioscience Partnership Advances Automation
openPR.com International Overview This article provides an overview of a market research report introduced by openPR.com, highlighting significant growth in the small-scale bioreactors market, driven by innovations in bioprocessing effic... -
Chemically Defined Media Accelerates Biopharmaceutical Manufacturing with Enhanced Consistency and Regulatory Compliance
CASRAI Unknown Overview The biopharmaceutical industry is rapidly adopting Chemically Defined Media (CDM) to significantly improve cell culture consistency and regulatory compliance by eliminating undefined biological components. CDM ens... -
Transforming Cell Therapy: New Report Projects Shift to Cost-Effective Manufacturing by 2035
Roots Analysis India Overview A new report from Roots Analysis, 'Cell Therapy Manufacturing Market 2035,' predicts a critical shift towards more standardized, reproducible, and cost-effective production models. This transformation is dri... -
Chime Biologics Unveils AI-Driven Biomanufacturing Future with New Wuhan GMP-2 Facility and 100+ Bioreactor Megafactory Vision
BioPharma APAC China Overview Chime Biologics has significantly bolstered its biopharmaceutical manufacturing capabilities with the opening of its GMP-2 facility in Wuhan, China, equipped with eight Cytiva 2,000-liter single-use Xcellere... -
AGC Biologics Secures Landmark Multi-Hundred-Million-Dollar Deal for Yokohama Facility, Cementing Japan’s Biologics Manufacturing Leadership
AGC Biologics Japan Overview AGC Biologics has secured a multi-year, multi-hundred-million-dollar commercial manufacturing agreement for its new Yokohama facility, slated to open in 2027. This landmark deal dedicates approximately half o... -
Reusable Bioreactor Market Surges: Driven by Large-Volume Biologics Production and CDMO Capacity Expansion, Hybrid Manufacturing Emerges
Constancy Researchers USA Overview The reusable bioreactor market is experiencing substantial growth, propelled by the increasing demand for large-volume commercial biopharmaceutical production and the expansion of CDMO capacities. A not... -
Thermo Fisher Unveils DynaDrive 5L Single-Use Bioreactor, Enabling Seamless 1L to 5,000L Scale-Up for Biologics Manufacturing
Constancy Researchers USA Overview Thermo Fisher Scientific has launched its DynaDrive 5L single-use bioreactor, designed to enhance workflow efficiency in biopharmaceutical manufacturing. This new system facilitates seamless culture sca... -
EU NK Cell Market Projected for Twofold Growth by 2035, Driven by Increasing Allogeneic NK Cell Therapy Approvals
IndexBox USA Overview This article outlines a report from IndexBox on the European Union's NK cell market, which is expected to double in size between 2026 and 2035. This growth is primarily driven by the approval and commercial launch o... -
Cytiva CEO Pierre-Alain Ruffieux Emphasizes Standardization and Automation for Scaling Cell and Gene Therapy Manufacturing Ahead of BIO 2026
BioPharm International USA Overview Ahead of BIO International Convention 2026, Cytiva CEO Pierre-Alain Ruffieux discussed scaling cell and gene therapy (CGT) manufacturing to expand global access. He emphasized standardization and autom... -
Cytiva Achieves Enhanced mAb Variant Separation and Purity Using IEX and Multimodal Resins, Optimizing Elution pH with Capto SP ImpRes
Cytiva USA Overview Cytiva's latest research demonstrates a significant improvement in separating charged monoclonal antibody (mAb) variants and achieving higher purity using ion exchange (IEX) and multimodal resins. Specifically, optimi...
12